Disease Subtype(s) HCT Disease Inserts required Cellular Therapy Disease Inserts required
AML with recurrent genetic abnormalities
  • AML with t(9;11) (p22.3;q23.3); MLLT3-KMT2A (5)
  • AML with t(6;9) (p23;q34.1); DEK-NUP214 (6)
  • AML with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM (7)
  • AML (megakaryoblastic) with t(1;22) (p13.3;q13.3); RBM15-MKL1 (8)
  • AML with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 (281)
  • AML with inv(16)(p13.1;1q22) or t(16;16)(p13.1; q22); CBFB-MYH11 (282)
  • APL with PML-RARA (283)
  • AML with BCR-ABL1 (provisional entity) (3)
  • AML with mutated NPM1 (4)
  • AML with biallelic mutations of CEBPA (297)
  • AML with mutated RUNX1 (provisional entity) (298)
  • AML with 11q23 (MLL) abnormalities (i.e., t(4;11), t(6;11), t(9;11), t(11;19)) (284)
  • AML with myelodysplasia – related changes (285)
  • Therapy related AML (t-AML) (9)
Forms 2010 & 2110 No disease inserts required
AML, not otherwise specified
  • AML, not otherwise specified (280)
  • AML, minimally differentiated (286)
  • AML without maturation (287)
  • AML with maturation (288)
  • Acute myelomonocytic leukemia (289)
  • Acute monoblastic / acute monocytic leukemia (290)
  • Acute erythroid leukemia (erythroid / myeloid and pure erythroleukemia) (291)
  • Acute megakaryoblastic leukemia (292)
  • Acute basophilic leukemia (293)
  • Acute panmyelosis with myelofibrosis (294)
  • Myeloid sarcoma (295)
  • Myeloid leukemia associated with Down syndrome (299)
Forms 2010 & 2110
Last modified: 2017/06/27

Feedback

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.

Post your comment on this topic.

Please do not use this for support questions.
For customer support, please contact us here.

Post Comment